Baidu
map

西门子医疗创新产品与解决方案亮相第31届国际医疗仪器设备展览会

2019-03-22 不详 美通社

在北京举办的第31届国际医疗仪器设备展览会上,西门子医疗聚焦部队医院高端、高效以及实地救治的需求,展出多款新品和解决方案,全面展示公司在推进精准医疗、转化诊疗模式方面的成果与进展,彰显西门子医疗为实现“健康中国2030”规划所做出的承诺和努力。 第31届国际医疗仪器设备展览会西门子医疗展台 在北京举办的第31届国际医疗仪器设备展览会上,西门子医疗展出多款新品和解决方案,全面展示公司在推进精准医疗

在北京举办的第31届国际医疗仪器设备展览会上,西门子医疗聚焦部队医院高端、高效以及实地救治的需求,展出多款新品和解决方案,全面展示公司在推进精准医疗、转化诊疗模式方面的成果与进展,彰显西门子医疗为实现“健康中国2030”规划所做出的承诺和努力。

第31届国际医疗仪器设备展览会西门子医疗展台
第31届国际医疗仪器设备展览会西门子医疗展台

在北京举办的第31届国际医疗仪器设备展览会上,西门子医疗展出多款新品和解决方案,全面展示公司在推进精准医疗、转化诊疗模式方面的成果与进展,彰显西门子医疗为实现“健康中国2030”规划所做出的承诺和努力。

高精尖产品助力推进精准医疗

西门子医疗始终致力于尖端医疗技术的研发和生产,以影像诊断临床诊疗、实验室诊断等领域的多元产品组合,助力国防医疗顶级科研临床,推进精准医疗。

西门子医疗在本届展会上展出的多款高精尖产品,助力部队医院临床诊疗精准化。

  • 新一代PET/MR成像系统Biograph mMR,结合新指南针技术平台,实现一体化PET/MR。从同时、同步采集向全身协同采集进化,借助协同采集技术,可消除呼吸、头动等生理运动带来的图像伪影,提升小病灶检出率,提高标准摄取值(SUV)定量值准确性。
  • 最新超声影像设备ACUSON Sequoia,基于BioAcousticTM生物声学平台,最大限度适应不同体型的患者。临床穿透深度可达40厘米,提供更精准和全面的临床诊断信息。
  • 新一代全自动生化免疫分析系统Atellica® 解决方案的高自动化程度以及快速准确的检测能力,可从掌控力、便捷性、快速稳定准确的检测结果方面全面提升实验室检验能力,优化实验室临床运营。
西门子医疗员工介绍产品
西门子医疗员工介绍产品

智能化系统强化实地救治能力

医疗智能化与数字化助力国防医疗快速、高效,提升实地救治能力。

近二十年来,西门子医疗在设备智能化方面取得了一系列创新成果:在人工智能的科研领域拥有500多项机器学习领域的专利、100多项深度学习领域的基本专利、并研发了40多项人工智能应用的产品。Syngo虚拟座舱(Syngo Virtual Cockpit)提供远程扫描读片协助,帮助边远地区和基层医院应对专业人才短缺的挑战。可同时识别和测定胸部CT影像的多种器官和病灶,自动形成量化报告的全球首创人工智能产品 -- AI-Rad Chest CT,为医护人员的快速高效诊断提供得力助手。

通过一体化软件整合平台(syngo RT suit),携手放疗治疗合作伙伴,西门子医疗的放疗影像全面解决方案提供了一整套精准治疗手段。医生可以根据每个病患的病理、解剖等数据制定个性化的治疗方案,或是几种治疗方式相结合,以期达到理想治疗结果。

西门子医疗展出的基于云端的大数据平台teamplay,通过连接医疗机构及其成像设备,全面了解到医疗机构影像设备使用情况,更好地帮助其快速高效地收集和分析影像设备产生的海量数据,并实现医院、影像专家、成像设备的交互和连通,帮助提升实地救治能力。面向医务工作者的专业化、个性化云端医学教育平台PEPconnect旨在提升医护人员个人专业能力、提高工作效率并改善诊疗效果。第二代服务在线管理平台设备管理工具LifeNet的实时监控、计划服务和文档管理三大功能向医疗机构提供实时互动、高效透明的服务,最大程度减少停机时间、助力其提升价值。

最新发布的64排128层计算机断层扫描仪SOMATOM go.Top能满足“快速反应,快速救治,快速解决问题”的野战医院救治需求。可实现无极变档,13档电压(KV)为精准影像提供个性化的诊断信息;每圈0.33秒的扫描速度,为开展快速全身CT扫描检查提供了保证;搭载AI集成平台、配备掌上无线平板电脑,不仅简化了工作流程,而且实现了AI前处理,即拍即诊断。

西门子医疗大中华区总裁王皓先生表示:“本次参展China Med的多款创新产品和解决方案体现了我们推进精准医疗、转化诊疗模式方面的实践和进展,更诠释了西门子医疗‘助力医疗服务提供者提升价值’的使命。提升医疗服务质量和可及性,为实现‘健康中国2030’规划做贡献是我们矢志努力的目标和动力。”

关于西门子医疗

西门子医疗致力于通过支持全球医疗服务提供者在各自领域推进精准医疗、转化诊疗模式、改善患者体验以及实现数字化医疗,以全方位助力其提升价值。作为医疗科技领域的领导者,西门子医疗始终致力于产品组合的创新,并着力完善核心业务 -- 影像诊断、临床诊疗与实验室诊断、分子医学的配套服务业务系统。此外,西门子医疗更积极推进其在数字健康服务与医疗企业管理方案领域的业务延伸。

2018财年(截至2018年9月30日),西门子医疗业务的总营收为134亿欧元,调整后的利润额为23亿欧元。目前,西门子医疗在全球拥有约50,000名员工。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1666912, encodeId=50b01666912d7, content=<a href='/topic/show?id=f2b0905506a' target=_blank style='color:#2F92EE;'>#西门子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90550, encryptionId=f2b0905506a, topicName=西门子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e226073684, createdName=bshuang, createdTime=Sun Oct 27 13:41:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988013, encodeId=2c0b198801311, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 09 08:41:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741160, encodeId=54881e411600e, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Mon May 20 17:41:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080484, encodeId=5b562080484a2, content=<a href='/topic/show?id=f22e320983f' target=_blank style='color:#2F92EE;'>#创新产品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32098, encryptionId=f22e320983f, topicName=创新产品)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Thu Dec 19 14:41:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285722, encodeId=43d01285e2227, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604669, encodeId=4dcd16046691d, content=<a href='/topic/show?id=d3689055158' target=_blank style='color:#2F92EE;'>#西门子医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90551, encryptionId=d3689055158, topicName=西门子医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e34419265734, createdName=1249842em15(暂无昵称), createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=)]
    2019-10-27 bshuang
  2. [GetPortalCommentsPageByObjectIdResponse(id=1666912, encodeId=50b01666912d7, content=<a href='/topic/show?id=f2b0905506a' target=_blank style='color:#2F92EE;'>#西门子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90550, encryptionId=f2b0905506a, topicName=西门子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e226073684, createdName=bshuang, createdTime=Sun Oct 27 13:41:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988013, encodeId=2c0b198801311, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 09 08:41:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741160, encodeId=54881e411600e, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Mon May 20 17:41:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080484, encodeId=5b562080484a2, content=<a href='/topic/show?id=f22e320983f' target=_blank style='color:#2F92EE;'>#创新产品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32098, encryptionId=f22e320983f, topicName=创新产品)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Thu Dec 19 14:41:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285722, encodeId=43d01285e2227, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604669, encodeId=4dcd16046691d, content=<a href='/topic/show?id=d3689055158' target=_blank style='color:#2F92EE;'>#西门子医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90551, encryptionId=d3689055158, topicName=西门子医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e34419265734, createdName=1249842em15(暂无昵称), createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1666912, encodeId=50b01666912d7, content=<a href='/topic/show?id=f2b0905506a' target=_blank style='color:#2F92EE;'>#西门子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90550, encryptionId=f2b0905506a, topicName=西门子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e226073684, createdName=bshuang, createdTime=Sun Oct 27 13:41:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988013, encodeId=2c0b198801311, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 09 08:41:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741160, encodeId=54881e411600e, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Mon May 20 17:41:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080484, encodeId=5b562080484a2, content=<a href='/topic/show?id=f22e320983f' target=_blank style='color:#2F92EE;'>#创新产品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32098, encryptionId=f22e320983f, topicName=创新产品)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Thu Dec 19 14:41:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285722, encodeId=43d01285e2227, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604669, encodeId=4dcd16046691d, content=<a href='/topic/show?id=d3689055158' target=_blank style='color:#2F92EE;'>#西门子医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90551, encryptionId=d3689055158, topicName=西门子医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e34419265734, createdName=1249842em15(暂无昵称), createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1666912, encodeId=50b01666912d7, content=<a href='/topic/show?id=f2b0905506a' target=_blank style='color:#2F92EE;'>#西门子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90550, encryptionId=f2b0905506a, topicName=西门子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e226073684, createdName=bshuang, createdTime=Sun Oct 27 13:41:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988013, encodeId=2c0b198801311, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 09 08:41:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741160, encodeId=54881e411600e, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Mon May 20 17:41:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080484, encodeId=5b562080484a2, content=<a href='/topic/show?id=f22e320983f' target=_blank style='color:#2F92EE;'>#创新产品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32098, encryptionId=f22e320983f, topicName=创新产品)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Thu Dec 19 14:41:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285722, encodeId=43d01285e2227, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604669, encodeId=4dcd16046691d, content=<a href='/topic/show?id=d3689055158' target=_blank style='color:#2F92EE;'>#西门子医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90551, encryptionId=d3689055158, topicName=西门子医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e34419265734, createdName=1249842em15(暂无昵称), createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1666912, encodeId=50b01666912d7, content=<a href='/topic/show?id=f2b0905506a' target=_blank style='color:#2F92EE;'>#西门子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90550, encryptionId=f2b0905506a, topicName=西门子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e226073684, createdName=bshuang, createdTime=Sun Oct 27 13:41:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988013, encodeId=2c0b198801311, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 09 08:41:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741160, encodeId=54881e411600e, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Mon May 20 17:41:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080484, encodeId=5b562080484a2, content=<a href='/topic/show?id=f22e320983f' target=_blank style='color:#2F92EE;'>#创新产品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32098, encryptionId=f22e320983f, topicName=创新产品)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Thu Dec 19 14:41:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285722, encodeId=43d01285e2227, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604669, encodeId=4dcd16046691d, content=<a href='/topic/show?id=d3689055158' target=_blank style='color:#2F92EE;'>#西门子医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90551, encryptionId=d3689055158, topicName=西门子医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e34419265734, createdName=1249842em15(暂无昵称), createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1666912, encodeId=50b01666912d7, content=<a href='/topic/show?id=f2b0905506a' target=_blank style='color:#2F92EE;'>#西门子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90550, encryptionId=f2b0905506a, topicName=西门子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e226073684, createdName=bshuang, createdTime=Sun Oct 27 13:41:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988013, encodeId=2c0b198801311, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 09 08:41:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741160, encodeId=54881e411600e, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Mon May 20 17:41:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080484, encodeId=5b562080484a2, content=<a href='/topic/show?id=f22e320983f' target=_blank style='color:#2F92EE;'>#创新产品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32098, encryptionId=f22e320983f, topicName=创新产品)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Thu Dec 19 14:41:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285722, encodeId=43d01285e2227, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604669, encodeId=4dcd16046691d, content=<a href='/topic/show?id=d3689055158' target=_blank style='color:#2F92EE;'>#西门子医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90551, encryptionId=d3689055158, topicName=西门子医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e34419265734, createdName=1249842em15(暂无昵称), createdTime=Sun Mar 24 13:41:00 CST 2019, time=2019-03-24, status=1, ipAttribution=)]

相关资讯

2019年2月20日,由中华国际医学交流基金会与西门子医疗联合举办的2019智能医疗高峰论坛在北京召开。超过150位来自政府、行业协会、医疗机构的领导和专家们,

2019年2月20日,由中华国际医学交流基金会与西门子医疗联合举办的2019智能医疗高峰论坛在北京召开。超过150位来自政府、行业协会、医疗机构的领导和专家们,以及来自阿里健康、平安好医、腾讯医疗、深睿、依图、推想、科大讯飞、柏视医疗、数坤、图码深维、雅森、筑医台、安德医智、希氏异构等医疗人工智能公司的负责人齐聚一堂,共同探讨医疗数字化在全球以及中国的发展现状与趋势,以及医疗行业在人工智能及数字化

西门子医疗发布新一代全自动生化免疫分析系统Atellica(R)解决方案

今日,中国医学装备协会检验医学分会一带一路检验装备学组与西门子医疗携手举办“一带一路,中欧新检验实践高峰论坛 -- 精益管理, 走向临床”,就精益化管理落地、数字化、新检验标志物的临床意义等一系列热点话题进行了深入探讨。论坛上,西门子医疗发布新一代全自动生化免疫分析系统Atellica®,通过高自动化程度与快速准确的检测能力促进实验室检验能力的全面提升。在论坛的尾声,新版《临床实验诊断学

Baidu
map
Baidu
map
Baidu
map